Loading...

Singapore to be GSK’s base for growth in Asia

Image

12-Mar-15 Pharmaceutical giant GSK has announced that it will use Singapore as a base to steer its growth in Asia, with the set-up of a new regional headquarters there. The new HQ will be “one of three co-global ‘control towers’ alongside the UK and US, with the full suite of capabilities and autonomy to make decisions in Asia, for Asia". [image: Reuters]

Read More

Doctors in Vietnam urge correct use of medicines

Image

10-Mar-15 The over-use of antibiotics stemming from both healthcare providers and patients, low-quality antibiotics and incorrect dosages have led to a serious increase in antibiotic resistance in Vietnam. As a result, healthcare costs and treatment times have both risen. Doctors are urging correct use of medicines to avoid an escalation in diseases such as pneumonia. [image: Vietnam News]

Read More

China Jo-Jo joins Alibaba Health e-prescription platform

Image

12-Feb-15 Through Alibaba Health's new mobile app, Alijk, patients can now upload and send a prescription to a nearby pharmacy to check the availability of medicines, compare prices and eventually make a payment. Pharmacies partnering with Alibaba Health, such as China Jo-Jo which has recently joined the platform, can then fulfil orders in-store or by home delivery. [image: Healthcare Innovation]

Read More

Antibiotic resistance in Cambodia sparks new health policy

Image

11-Feb-15 In Cambodia, resistance to antibiotics has become a public health problem worthy of a national response. Regulations for the sale of antibiotics are not enforced and antibiotics are a big source of income for pharmacists. Over the past 12 months, together with the WHO, the health ministry has developed a National Policy and a three year implementation plan. [image: PharmaD India]

Read More

Ageing China draws investors to its "hot" healthcare sector

Image

10-Feb-15 Encouraged by a relaxation of ownership rules in 2014 and a rapidly ageing population, PE firms and industry players are investing in China’s hospitals, pharmaceutical companies and device makers. The prospect of 223 million people aged 65+ by 2030 is enticing, despite risks such as rising valuations and a dearth of doctors. [image: Reuters]

Read More
Share